Association of Hemoglobin A1c Levels With All-Cause Mortality in Patients With Coronary Artery Disease
In the present large registry of patients with established coronary artery disease (CAD) undergoing coronary revascularization therapy, HbA1c levels display a U-shaped association with all-cause mortality. In addition to patients with diabetes, also patients with CAD with very low HbA1c face increased mortality risk. Clinical trials, randomizing to different HbA1c targets are needed to define optimal HbA1c targets for patients with established CAD.
Authors
- Iryna Dykun (ORCID: https://orcid.org/0000-0002-7350-1477)
- Tienush Rassaf (ORCID: https://orcid.org/0000-0001-8001-0265)
- Amir Abbas Mahabadi (ORCID: https://orcid.org/0000-0003-2336-7991)
- Rolf Alexander Jánosi (ORCID: https://orcid.org/0000-0002-9966-6886)
- Matthias Totzeck (ORCID: https://orcid.org/0000-0001-7898-3906)
- Jürgen Kampf (ORCID: https://orcid.org/0000-0001-8370-6882)
- Olga Babinets
- Natalie Kappo
Institutions
- University of Duisburg-Essen (DE)
Publication Details
- Journal
- JACC Advances
- Published
- 2025-02-21
- DOI
- https://doi.org/10.1016/j.jacadv.2025.101624
- Citations
- 2
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 2.59